Certara Balance Sheet Health

Financial Health criteria checks 5/6

Certara has a total shareholder equity of $1.0B and total debt of $291.2M, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are $1.6B and $516.3M respectively. Certara's EBIT is $14.1M making its interest coverage ratio 0.6. It has cash and short-term investments of $239.4M.

Key information

27.8%

Debt to equity ratio

US$291.24m

Debt

Interest coverage ratio0.6x
CashUS$239.42m
EquityUS$1.05b
Total liabilitiesUS$516.30m
Total assetsUS$1.56b

Recent financial health updates

No updates

Recent updates

When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Apr 11
When Should You Buy Certara, Inc. (NASDAQ:CERT)?

Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Mar 21
Certara, Inc.'s (NASDAQ:CERT) Share Price Could Signal Some Risk

Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Feb 17
Returns Are Gaining Momentum At Certara (NASDAQ:CERT)

Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth

Jan 30

Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Dec 07
Calculating The Fair Value Of Certara, Inc. (NASDAQ:CERT)

Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Oct 31
Risks To Shareholder Returns Are Elevated At These Prices For Certara, Inc. (NASDAQ:CERT)

Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

Sep 17
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?

An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

Aug 30
An Intrinsic Calculation For Certara, Inc. (NASDAQ:CERT) Suggests It's 29% Undervalued

Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue

Aug 03
Certara (NASDAQ:CERT) Shareholders Will Want The ROCE Trajectory To Continue

Certara: A Story To Watch

Sep 27

Certara to raise capital in secondary stock offering

Aug 12

Certara Looks Positioned For Increased Growth In 2022

Feb 02

Certara: Global Biosimulation Firm Positions Itself For Stability Into The Long Term

Sep 29

Financial Position Analysis

Short Term Liabilities: CERT's short term assets ($340.2M) exceed its short term liabilities ($130.0M).

Long Term Liabilities: CERT's short term assets ($340.2M) do not cover its long term liabilities ($386.3M).


Debt to Equity History and Analysis

Debt Level: CERT's net debt to equity ratio (4.9%) is considered satisfactory.

Reducing Debt: CERT's debt to equity ratio has reduced from 82.8% to 27.8% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable CERT has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: CERT is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 29.5% per year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.